Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Potential Role of H-Ferritin in Mitigating Valvular MineralizationArteriosclerosis, Thrombosis, and Vascular Biology.  39:413-431. 2019
2019 Ferritin Light Chain Confers Protection Against Sepsis-Induced Inflammation and Organ InjuryFrontiers in Immunology.  10:131. 2019
2019 Renal control of disease tolerance to malariaProceedings of the National Academy of Sciences.  116:5681-5686. 2019
2017 Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney InjuryAmerican Journal of Kidney Diseases.  69:531-545. 2017
2016 Heme oxygenases in cardiovascular health and diseasePhysiological Reviews.  96:1449-1508. 2016
2016 Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injuryAJP - Renal Physiology.  310:F385-F394. 2016
2016 Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogramInternational Urology and Nephrology.  48:271-277. 2016
2016 Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cellsJournal of Cellular and Molecular Medicine.  20:217-230. 2016
2015 Macrophage and epithelial cell H-ferritin expression regulates renal inflammationKidney International.  88:95-108. 2015
2014 Erratum to: Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis [Clinical and Experimental Nephrology, DOI 10.1007/s10157-014-0950-9]Clinical and Experimental Nephrology.  18:960. 2014
2014 Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysisClinical and Experimental Nephrology.  18:952-959. 2014
2013 Proximal tubule h-ferritin mediates iron trafficking in acute kidney injuryJournal of Clinical Investigation.  123:4423-4434. 2013
2013 Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cellsAJP - Renal Physiology.  305. 2013
2013 C-reactive protein exacerbates renal ischemia-reperfusion injuryAJP - Renal Physiology.  304:1358-1365. 2013
2013 Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic functionBMC Nephrology.  14. 2013
2012 Superoxide in AVF dysfunction: A new target for interventionAJP - Renal Physiology.  303. 2012
2012 A reproducible mouse model of chronic allograft nephropathy with vasculopathyKidney International.  82:1231-1235. 2012
2012 Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in miceArthritis and Rheumatism.  64:4114-4124. 2012
2012 In vivo regulation of the heme oxygenase-1 gene in humanized transgenic miceKidney International.  82:278-291. 2012
2012 Heme Oxygenase-1 as a Target for TGF-β in Kidney DiseaseSeminars in Nephrology.  32:277-286. 2012
2012 Enabling Innovative Translational Research in Acute Kidney InjuryClinical and Translational Science.  5:93-101. 2012
2011 Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cellsKidney International.  80:731-739. 2011
2011 Identification of a microRNA signature in renal fibrosis: Role of miR-21AJP - Renal Physiology.  301. 2011
2011 Sepsis and acute kidney injuryJournal of the American Society of Nephrology.  22:999-1006. 2011
2011 ATP as a death factor: Purinergic signaling in renal epithelial-fibroblast cross talkAJP - Renal Physiology.  300. 2011
2011 Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1AJP - Renal Physiology.  300. 2011
2010 Ferritin ferroxidase activity: A potent inhibitor of osteogenesisJournal of Bone and Mineral Research.  25:164-172. 2010
2009 Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cellsJournal of the American Society of Nephrology.  20:1254-1263. 2009
2009 Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H2S)Free Radical Biology and Medicine.  46:616-623. 2009

Chapter

Year Title Altmetric
2012 Ferritin/ferroxidase activity: A potent inhibitor of vascular calcification, osteoblastic transdifferentiation of vascular smooth muscle cells and osteoblast activity.  83-100. 2012

Education And Training

  • UAB Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, University of Debrecen 2006
  • Full Name

  • Abolfazl Zarjou